Details
Aminasin Indications
Chronic paranoid and hallucinatory-paranoid state, the state of agitation in schizophrenia (hallucinatory-delusional, hebephrenic, catatonic syndromes), alcoholic psychosis, manic excitement in manic-depressive psychosis, mental disorders in epilepsy, agitated depression in patients with presenile psychosis, manic depressive psychosis, as well as other diseases, accompanied by excitation voltage.
Neurological diseases accompanied by increased muscle tone.
Meniere's disease, emesis, treatment and prevention of emesis in the treatment with anticancer agents and radiotherapy.
Itchy dermatitis.
In the combined therapy: Persistent pain, incl causalgia (in combination with analgesics), sleep disorders resistant nature (in combination with hypnotics and tranquilizers).
Dosage & Administration
Assign inside after eating.
Doses and frequency of administration regimen are set individually depending on the indication and patient condition. Dosages should be adjusted by increasing from a minimum. Duration of treatment - from 2 weeks to 3 - 4 months or more. Schizophrenia and other psychoses, and psychomotor agitation. Adult starting dose of 25-75 mg (1-3 tablets) per day, divided into 2 - 3 doses. Further the dose can be gradually increased to 300-600 mg (12-24 tablets) per day by dividing it in 3 - 4 divided doses. The highest single dose - 300 mg, daily - 1 g
Elderly patients with diseases of the liver and cardiovascular system, reduce the dose to 2 - 3 times.
Babies (schizophrenia and autism), aged 5 to 12 years, administered 1/3 - ½ the adult dose; the highest daily dose - 75 mg (3 tablets). Children aged 1 to 5 years, is prescribed 0.5 mg / kg every 4-6 hours; the highest daily dose - 40 mg.
Contraindications
Increased individual sensitivity to chlorpromazine and other ingredients; severe liver and / or kidney, blood-forming organs, progressive system of the brain and spinal cord diseases,
